Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Elraglusib |
Trade Name | |
Synonyms | 9 ING 41|9-ING-41 |
Drug Descriptions |
Elraglusib is an ATP-competitive inhibitor that selectively blocks GSK-3beta, potentially leading to cell cycle arrest and apoptosis, inhibition of tumor cell proliferation, and decreased tumor growth (PMID: 31894292, PMID: 29846250). |
DrugClasses | GSK-3beta Inhibitor 4 |
CAS Registry Number | 1034895-42-5 |
NCIT ID | C156792 |